All articles by Surya Rao Akella

Surya Rao Akella

PredictImmune to launch PredictSURE IBD biomaker test in UK and Europe

PredictImmune stated that achievement marks significant progress towards enhancing treatment and outcomes for IBD patients in the UK and Europe.…

Roche partners with Merck to develop companion diagnostic test

Roche will develop companion diagnostic for use with Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in advanced solid tumors with mismatch repair…

InterVenn raises $9.4m to accelerate development of AI-driven mass spectrometry platform

The financing will be used to develop the company’s first product, a blood-based ovarian cancer diagnostic. Jenny Rooke founder and…

Glaukos says iStent inject implantation with cataract surgery can reduce IOP and medication burden

A single-site international study of glaucoma subjects recently published in Ophthalmology and Therapy showed that the iStent inject Trabecular Micro-Bypass…

Boston Scientific wins patent infringement litigation against Edwards Lifesciences

Edwards owes Boston Scientific infringement damages through the end of 2016. Additional damages and interest incurred from 2017-2018 will be…

Next Step Bionics announces breakthrough advancement in use of LUKE arm prosthesis

Junius Moore, 35, will become the world’s first recipient of an osseointegrated LUKE arm combined with post targeted muscle reinnervation…

AMRA Medical secures FDA approval for AMRA Profiler

AMRA Medical stated that AMRA Profiler can be used for non-invasive fat and muscle evaluation that enables the generation, display…

WhiteSwell secures $30m in series B funding round

WhiteSwell is involved in finding new ways to treat acute decompensated heart failure (ADHF), The company intends to use the…

BioCardia submits application in US for AVANCE Steerable Introducer

The AVANCE steerable introducer leverages new technology developed for BioCardia’s Morph family of steerable introducers and applies it for transseptal…

DiscGenics wins Japanese PMDA nod for clinical study of non-surgical degenerative disc disease treatment

IDCT is available off-the-shelf and offers a non-surgical therapeutic option for patients suffering from DDD. The CTN approval allows DiscGenics…